Received Oct 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | H4K3S | — |
Boostrix instead of Fluad; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of wrong vaccine administered in a 80-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number H4K3S, expiry date 30-OCT-2027) for prophylaxis. Co-suspect products included Influenza vaccine inact sAg 3v (Fluad) for prophylaxis. Concomitant products included Pneumococcal vaccine conj 20v (CRM197) (Prevnar 20). On 02-SEP-2025, the patient received Boostrix. The patient did not receive Fluad. On 02-SEP-2025, an unknown time after receiving Boostrix, the patient experienced wrong vaccine administered (Verbatim: Boostrix instead of Fluad). The outcome of the wrong vaccine administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 29-SEP-2025 A pharmacist had explained that on 2nd September 2025, patient had come in to receive pneumonia and flu vaccines, but had apparently been accidentally given Boostrix instead of Fluad. Patient had also received Prevnar 20 on the same day. Patient had not appeared to have received any prior doses of Tetanus, Diphtheria, or Pertussis vaccines.
PREVNAR 20